Literature DB >> 18321367

Absence of COSMC gene mutations in breast and colorectal carcinomas.

Nam Jin Yoo, Min Sung Kim, Sug Hyung Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18321367     DOI： 10.1111/j.1600-0463.2008.00965.x

Source DB:  PubMed          Journal:  APMIS        ISSN： 0903-4641            Impact factor:   3.205


× No keyword cloud information.
  16 in total

1.  Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.

Authors:  Xiaofeng Yu; Zhenzhen Du; Xuhong Sun; Chuanqin Shi; Huaixiang Zhang; Tao Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

Authors:  Tongzhong Ju; Yingchun Wang; Rajindra P Aryal; Sylvain D Lehoux; Xiaokun Ding; Matthew R Kudelka; Christopher Cutler; Junwei Zeng; Jianmei Wang; Xiaodong Sun; Jamie Heimburg-Molinaro; David F Smith; Richard D Cummings
Journal:  Proteomics Clin Appl       Date:  2013-09-09       Impact factor: 3.494

3.  Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.

Authors:  Rongjuan Mi; Lina Song; Yingchun Wang; Xiaokun Ding; Junwei Zeng; Sylvain Lehoux; Rajindra P Aryal; Jianmei Wang; Vanja K Crew; Irma van Die; Arlene B Chapman; Richard D Cummings; Tongzhong Ju
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 4.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

Review 5.  Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.

Authors:  Valeria da Costa; Teresa Freire
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

6.  MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

Authors:  Kristiaan Lenos; Jeroen A C M Goos; Ilona M Vuist; Sjoerd H den Uil; Pien M Delis-van Diemen; Eric J Th Belt; Hein B A C Stockmann; Herman Bril; Meike de Wit; Beatriz Carvalho; Susan Giblett; Catrin A Pritchard; Gerrit A Meijer; Yvette van Kooyk; Remond J A Fijneman; Sandra J van Vliet
Journal:  Oncotarget       Date:  2015-09-22

7.  C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.

Authors:  Ji-Shiang Hung; John Huang; Yo-Chuen Lin; Miao-Juei Huang; Po-Huang Lee; Hong-Shiee Lai; Jin-Tung Liang; Min-Chuan Huang
Journal:  Oncotarget       Date:  2014-04-30

Review 8.  The Role of Sialyl-Tn in Cancer.

Authors:  Jennifer Munkley
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

Review 9.  Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Authors:  Rita Azevedo; Andreia Peixoto; Cristiana Gaiteiro; Elisabete Fernandes; Manuel Neves; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Oncotarget       Date:  2017-07-21

10.  Sialyl-tn in cancer: (how) did we miss the target?

Authors:  Sylvain Julien; Paula A Videira; Philippe Delannoy
Journal:  Biomolecules       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.